Saiid Zarrabian Insider Trading
Get free email notifications about insider trading for Saiid Zarrabian.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Saiid Zarrabian. Saiid Zarrabian is a Director in LA JOLLA PHARMACEUTICAL CO ($LJPC) and a Director in PENWEST PHARMACEUTICALS CO ($PPCO) and a Director in DelMar Pharmaceuticals, Inc. ($DMPI) and a Interim CEO in DelMar Pharmaceuticals, Inc. ($DMPI) and a President and CEO in DelMar Pharmaceuticals, Inc. ($DMPI).
Address: 2981 ROUTE 22 SUITE 2 PATTERSON 12563-2335 NY
Companies in which Saiid Zarrabian is an Insider
Kintara Therapeutics, Inc.
Trading Symbol: KTRAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Saiid Zarrabian: President and CEO, Interim CEO, Director
Holdings: 55,000 shares
Latest Transaction: Sep 17 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
LA JOLLA PHARMACEUTICAL CO
Trading Symbol: LJPCIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Saiid Zarrabian: Director
Holdings: 688 shares
Current Value: $13,395
Latest Transaction: May 15 2015
$LJPC Market Capitalization: $355.22M
$LJPC Previous Close: $19.47
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PENWEST PHARMACEUTICALS CO
Trading Symbol: PPCOIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Saiid Zarrabian: Director
Holdings: 0 shares
Latest Transaction: Sep 22 2010
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Saiid Zarrabian
Sentiment: All, KTRA, LJPC, PPCO
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 17 2020 | DMPI | Kintara Therapeuti ... | Zarrabian Saiid | President and CEO | Option Exercise | A | 1.70 | 2,715,004 | 4,615,507 | 2,715,004 | |
Jun 30 2020 | DMPI | DelMar Pharmaceuti ... | Zarrabian Saiid | President and CEO | Option Exercise | A | 0.61 | 241,438 | 147,277 | 457,650 | |
Sep 09 2019 | DMPI | DelMar Pharmaceuti ... | Zarrabian Saiid | President and CEO | Option Exercise | A | 0.61 | 216,212 | 131,889 | 216,212 | |
Sep 09 2019 | DMPI | DelMar Pharmaceuti ... | Zarrabian Saiid | President and CEO | Option Exercise | A | 0.61 | 241,438 | 147,277 | 241,438 | |
May 01 2019 | DMPI | DelMar Pharmaceuti ... | Zarrabian Saiid | President and CEO | Option Exercise | D | 0.00 | 200,000 | 0 | 0 | |
May 22 2018 | DMPI | DelMar Pharmaceuti ... | Zarrabian Saiid | President and CEO | Option Exercise | A | 0.98 | 836,465 | 821,827 | 836,465 | |
Nov 16 2017 | DMPI | DelMar Pharmaceuti ... | Zarrabian Saiid | Interim CEO | Buy | P | 0.84 | 5,900 | 4,956 | 5,900 | 0 to 5.9 K |